Compare EXAS & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXAS | NWS |
|---|---|---|
| Founded | 1995 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3B | 16.2B |
| IPO Year | N/A | N/A |
| Metric | EXAS | NWS |
|---|---|---|
| Price | $101.91 | $30.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 6 |
| Target Price | ★ $77.94 | $37.34 |
| AVG Volume (30 Days) | ★ 4.9M | 982.0K |
| Earning Date | 02-18-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 230.83 |
| EPS | N/A | ★ 2.06 |
| Revenue | $3,082,033,000.00 | ★ $8,500,000,000.00 |
| Revenue This Year | $19.40 | $5.13 |
| Revenue Next Year | $13.51 | $3.30 |
| P/E Ratio | ★ N/A | $13.04 |
| Revenue Growth | ★ 14.47 | 2.20 |
| 52 Week Low | $38.81 | $26.25 |
| 52 Week High | $102.66 | $35.58 |
| Indicator | EXAS | NWS |
|---|---|---|
| Relative Strength Index (RSI) | 85.29 | 56.79 |
| Support Level | $101.45 | $29.81 |
| Resistance Level | $102.00 | $30.24 |
| Average True Range (ATR) | 0.39 | 0.46 |
| MACD | -1.26 | 0.07 |
| Stochastic Oscillator | 88.69 | 77.88 |
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.